2607: Shanghai Pharmaceuticals Holding Co., Ltd - Summary | Jitta

Shanghai Pharmaceuticals Holding Co., Ltd

HKG:2607

Price
HK$11.84
Loss Chance
43.2%
5.74JITTA SCORE
67.36%Under Jitta Line
Jitta Ranking
87 / 234
628 / 2,522
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (62)
Recent Business Performance (63)
Financial Strength (90)
Return to Shareholders (14)
Competitive Advantage (48)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
SG&A to SalesDecreasing Every Year
Revenue and EarningEarning decline from 2020-2025
Operating MarginDeclined
Key Stats
Jitta Score
Jitta Line
5.74
67.36%
3.82
189.55%
Health Care Distributors
2.68
100.00%
3.93
7.64%
5.09
33.75%
COMPANY DESCRIPTION
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.